TherageniX to receive powdered gene therapy grant
The funding will boost the University of Nottingham spinout’s development of bone regeneration treatment
Read More
Tag: gene
Evox Therapeutics reaches gene therapy agreement
Partnership with Icahn School of Medicine will involve developing exoAAV vectors for heart disease patients
Read More
Recommendation from NICE for PTC Therapeutics gene therapy
Eladocagene exuparvovec is for children with ultra-rare genetic disorder in final draft guidance
Read More
NICE approves funding for Novartis gene therapy
Funding is for onasemnogene abeparvovec and concerns babies with spinal muscular atrophy
Read More
CSL’s first gene therapy for haemophilia B approved
Boost for effected patients as HEMGENIX receives green light from European Commission
Read More
BaseCure collaborates with Aptamer Group to boost gene therapies
Binders will establish cell types and delivery vehicles may increase uptake of the siRNA therapy
Read More
Evotenix receives patent for gene synthesis method
Vital patent for Evotenix is anticipated to enable a new generation of DNA synthesis platforms
Read More
Gene team supports therapies for previously untreatable brain regions
Novartis and Voyager Therapeutics announce partnership to develop gene therapies for neurological disorders
Read More
Trial success for Lynparza in prostate cancer
The treatment is the only PARP inhibitor with positive Phase III results in four different cancer types – ovarian, breast, pancreatic and prostate.
Read More
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
